Recent research data surrounding this compound, specifically the high-dose formulation ZPHC ZPHC, reveal a considerable impact on body mass loss and linked chronic illnesses . Scientists anticipate that this combined compound, targeting both GLP-1 and GIP receptors , may provide a major breakthro